10.31.2023 - By JAMA Network
Who Should Get the New Alzheimer Disease Drug? Could Universal Donor Blood Be Made in the Lab? More Than 1 in 4 Nurses Say They Plan to Leave Health Care Related Content: Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug? Could Universal Donor Blood Be Made in the Laboratory? Overworked and Understaffed, More Than 1 in 4 US Nurses Say They Plan to Leave the Profession